Top 5 Medical Stocks To Watch For 2019

Clearside Biomedical Inc. (NASDAQ: CLSD) shares dropped early on Thursday after the company released data from its midstage clinical trial for diabetic macular edema (DME). Specifically, this data came from the Phase 2 clinical trial (TYBEE) evaluating suprachoroidal CLS-TA used with intravitreally administered Eylea (aflibercept).

Although the trial met its primary endpoint and even its secondary endpoint, Clearside’s treatment showed inferiority to the treatment it was being combined with. This ultimately was the catalyst for investors sending the shares lower.

The trial met its primary endpoint of mean improvement in best corrected visual acuity from baseline over six months as measured using the Early Treatment of Diabetic Retinopathy Trial (ETDRS) scale. Patients in the combination arm gained an average of 12.3 ETDRS letters, compared to 13.5 ETDRS letters in the Elyea alone control arm.

Additionally, the study met a key secondary endpoint, with a mean reduction from baseline of 208 microns in central subfield thickness (CST) of the retina at six months, compared to a 177 micron mean reduction in the control arm. Also, 93% of patients in the combination arm had a greater than 50% reduction in excess CST at six months, compared to 73% in the control.

Top 5 Medical Stocks To Watch For 2019: Collectors Universe, Inc.(CLCT)

Advisors’ Opinion:

  • [By Max Byerly]

    Media headlines about Collectors Universe (NASDAQ:CLCT) have been trending somewhat positive recently, Accern reports. The research group identifies positive and negative news coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Collectors Universe earned a media sentiment score of 0.02 on Accern’s scale. Accern also assigned media headlines about the business services provider an impact score of 46.6176420788428 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.

  • [By Shane Hupp]

    Press coverage about Collectors Universe (NASDAQ:CLCT) has trended somewhat positive on Saturday, Accern Sentiment Analysis reports. Accern ranks the sentiment of news coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Collectors Universe earned a media sentiment score of 0.05 on Accern’s scale. Accern also assigned news coverage about the business services provider an impact score of 45.3889072712147 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.

Top 5 Medical Stocks To Watch For 2019: Electro Scientific Industries, Inc.(ESIO)

Advisors’ Opinion:

  • [By Timothy Green]

    Shares of Electro Scientific Industries (NASDAQ:ESIO) soared on Thursday after the provider of laser-based manufacturing solutions reported solid first-quarter results. ESI beat analyst estimates for both revenue and earnings, and it provided guidance that was ahead of analyst expectations. As of 12:10 p.m. EDT, the stock was up about 20.8%.

  • [By Max Byerly]

    Divisar Capital Management LLC lifted its holdings in Electro Scientific Industries, Inc. (NASDAQ:ESIO) by 13.9% during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 780,167 shares of the semiconductor company’s stock after buying an additional 95,000 shares during the quarter. Electro Scientific Industries makes up about 4.0% of Divisar Capital Management LLC’s portfolio, making the stock its 11th biggest position. Divisar Capital Management LLC owned 2.29% of Electro Scientific Industries worth $12,303,000 as of its most recent SEC filing.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Electro Scientific Industries (ESIO)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Electro Scientific Industries (NASDAQ: ESIO) and FuelCell Energy (NASDAQ:FCEL) are both small-cap computer and technology companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, risk, profitability, dividends and earnings.

Top 5 Medical Stocks To Watch For 2019: National Commerce Corporation(NCOM)

Advisors’ Opinion:

  • [By Max Byerly]

    ValuEngine downgraded shares of National Commerce (NASDAQ:NCOM) from a hold rating to a sell rating in a research report released on Thursday.

    NCOM has been the subject of several other reports. BidaskClub upgraded shares of National Commerce from a buy rating to a strong-buy rating in a research report on Thursday, May 31st. Zacks Investment Research upgraded shares of National Commerce from a hold rating to a buy rating and set a $53.00 target price for the company in a research report on Wednesday, June 27th. Finally, Stephens reiterated a hold rating and set a $48.00 target price on shares of National Commerce in a research report on Thursday, July 26th. Two investment analysts have rated the stock with a sell rating and three have given a hold rating to the stock. The company currently has a consensus rating of Hold and an average target price of $48.67.

  • [By Shane Hupp]

    Citigroup Inc. trimmed its holdings in shares of National Commerce Corp (NASDAQ:NCOM) by 44.5% in the first quarter, Holdings Channel reports. The institutional investor owned 2,703 shares of the financial services provider’s stock after selling 2,171 shares during the period. Citigroup Inc.’s holdings in National Commerce were worth $118,000 as of its most recent SEC filing.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on National Commerce (NCOM)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    National Commerce (NASDAQ:NCOM) was downgraded by equities researchers at BidaskClub from a “strong-buy” rating to a “buy” rating in a research note issued on Saturday.

  • [By Joseph Griffin]

    The Manufacturers Life Insurance Company boosted its holdings in shares of National Commerce Corp (NASDAQ:NCOM) by 0.8% in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 223,067 shares of the financial services provider’s stock after acquiring an additional 1,798 shares during the quarter. The Manufacturers Life Insurance Company owned 1.29% of National Commerce worth $9,714,000 as of its most recent SEC filing.

Top 5 Medical Stocks To Watch For 2019: Magellan Midstream Partners L.P.(MMP)

Advisors’ Opinion:

  • [By Jason Hall]

    Let’s start with Magellan Midstream Partners (NYSE:MMP), ticker MMP. First thing to note here, distributable cash flow up 7% year over year. You notice I’m talking about cash flow. I’m not talking about earnings, I’m not talking about revenue. That’s because cash is king in this particular segment of the industry.

  • [By Matthew DiLallo]

    Meanwhile, the return multiples for many of the projects under development by Magellan Midstream Partners (NYSE:MMP) are in the six- to eight-times EBITDA range. Because of that, the $1.7 billion of expansion projects Magellan currently has underway only will generate about $250 million in incidental EBITDA. That’s partially why Magellan Midstream expects to grow its payout at a slower pace of 8% this year and a 5% to 8% annual rate in 2019 and 2020, even though it plans on paying out the same percentage of its cash flow as ONEOK.

  • [By Motley Fool Staff]

    Magellan Midstream Partners (NYSE:MMP) Q1 2018 Earnings Conference CallMay. 3, 2018 1:30 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

Top 5 Medical Stocks To Watch For 2019: CIENA Corporation(CIEN)

Advisors’ Opinion:

  • [By Billy Duberstein]

    For a great example, look no further than the recent note from MKM analyst Michael Genovese. Genovese anticipates large systems vendor Ciena (NYSE:CIEN) may end up stealing away large customer CenturyLink (NYSE:CTL) from smaller competitor Infinera (NASDAQ:INFN). That could be a huge win for Ciena and a huge blow to Infinera, and the episode is emblematic of this period in the industry.

  • [By Shane Hupp]

    A number of institutional investors have recently added to or reduced their stakes in the business. Neuberger Berman Group LLC increased its position in Ciena by 169.5% during the third quarter. Neuberger Berman Group LLC now owns 4,217,455 shares of the communications equipment provider’s stock worth $92,657,000 after buying an additional 2,652,791 shares in the last quarter. Millennium Management LLC increased its position in Ciena by 431.6% during the fourth quarter. Millennium Management LLC now owns 2,477,957 shares of the communications equipment provider’s stock worth $51,864,000 after buying an additional 2,011,805 shares in the last quarter. Maverick Capital Ltd. purchased a new position in Ciena during the fourth quarter worth $50,962,000. Renaissance Technologies LLC purchased a new position in Ciena during the fourth quarter worth $40,110,000. Finally, Rubric Capital Management LP purchased a new position in Ciena during the third quarter worth $33,373,000.

    ILLEGAL ACTIVITY WARNING: “Gary B. Smith Sells 8,000 Shares of Ciena (CIEN) Stock” was published by Ticker Report and is the sole property of of Ticker Report. If you are viewing this story on another publication, it was illegally stolen and reposted in violation of United States & international copyright & trademark laws. The legal version of this story can be accessed at www.tickerreport.com/banking-finance/3352094/gary-b-smith-sells-8000-shares-of-ciena-cien-stock.html.

    About Ciena

  • [By Motley Fool Transcribing]

    Ciena (NYSE:CIEN) Q3 2018 Earnings Conference CallAug. 30, 2018 8:30 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Dan Caplinger]

    The stock market took a breather on Thursday, and the Dow Jones Industrial Average and S&P 500 both gave up about half a percent. Investors seemed content to accept a pause in the late-summer rally, and some pointed to ongoing fears about still-unresolved trade disputes and other global macroeconomic stresses that could become more problematic in the future. Yet even with the overall market taking a break, some stocks pushed sharply higher. Insys Therapeutics (NASDAQ:INSY), Signet Jewelers (NYSE:SIG), and Ciena (NYSE:CIEN) were among the best performers on the day. Here’s why they did so well.

  • [By Logan Wallace]

    Akoustis Technologies (NYSE: CIEN) and Ciena (NYSE:CIEN) are both computer and technology companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, profitability, analyst recommendations, dividends, risk, valuation and institutional ownership.

  • [By Ezra Schwarzbaum]

    Several other optics stocks stand to gain. In a Monday note, Bank of America Merrill Lynch analyst Vivek Arya also highlighlited the semiconductor space as one that could benefit from the news. Other stocks to watch include:

    Lumentum Holdings Inc (NASDAQ: LITE)
    Ciena Corporation (NYSE: CIEN)
    Coherent, Inc. (NASDAQ: COHR)
    II-VI, Inc. (NASDAQ: IIVI)
    Inphi Corporation (NYSE: IPHI)
    Skyworks Solutions Inc (NASDAQ: SWKS)
    Integrated Device Technology Inc (NASDAQ: IDTI)
    Qorvo Inc (NASDAQ: QRVO)
    Xilinx, Inc. (NASDAQ: XLNX)
    Broadcom Inc (NASDAQ: AVGO)

    Related Links:

Leave a Reply

Your email address will not be published. Required fields are marked *